Document is current
Any future updates will be listed below
-
Authors
Mathalon, Daniel H. https://orcid.org/0000-0001-6090-4974
Nicholas, Spero
Roach, Brian J. https://orcid.org/0000-0002-3264-1465
Billah, Tashrif
Lavoie, Suzie https://orcid.org/0000-0001-8372-2399
Whitford, Thomas
Hamilton, Holly K. https://orcid.org/0000-0002-4058-0949
Addamo, Lauren
Anohkin, Andrey
Bekinschtein, Tristan
Belger, Aysenil https://orcid.org/0000-0003-2687-1966
Buccilli, Kate
Cahill, John
Carrión, Ricardo E. https://orcid.org/0000-0002-6393-392X
Damiani, Stefano https://orcid.org/0000-0002-5235-0788
Dzafic, Ilvana
Ebdrup, Bjørn H.
Izyurov, Igor
Jarcho, Johanna
Jenni, Raoul https://orcid.org/0000-0001-6479-5381
Jo, Anna https://orcid.org/0000-0002-9820-5826
Kerins, Sarah
Lee, Clarice
Martin, Elizabeth A. https://orcid.org/0000-0001-8893-1667
Mayol-Troncoso, Rocio https://orcid.org/0000-0002-6421-8768
Niznikiewicz, Margaret A. https://orcid.org/0000-0003-3191-2005
Parvaz, Muhammad
Pogarell, Oliver https://orcid.org/0000-0001-6455-4190
Prieto-Montalvo, Julio https://orcid.org/0000-0001-7711-0601
Rabin, Rachel https://orcid.org/0000-0002-6530-0288
Roalf, David R.
Rogers, Jack
Salisbury, Dean F.
Shaik, Riaz
Shankman, Stewart https://orcid.org/0000-0002-8097-4483
Stevens, Michael C.
Suen, Yi Nam
Swann, Nicole C.
Tang, Xiaochen https://orcid.org/0000-0003-3796-7111
Thompson, Judy L.
Tso, Ivy https://orcid.org/0000-0002-0984-1186
Wenzel, Julian https://orcid.org/0000-0002-3657-4263
Zhou, Juan Helen https://orcid.org/0000-0002-0180-8648
Addington, Jean https://orcid.org/0000-0002-8298-0756
Alameda, Luis https://orcid.org/0000-0002-8621-2885
Arango, Celso https://orcid.org/0000-0003-3382-4754
Breitborde, Nicholas J. K.
Broome, Matthew R. https://orcid.org/0000-0002-6963-8884
Cadenhead, Kristin S. https://orcid.org/0000-0002-5952-4605
Calkins, Monica E.
Castillo-Passi, Rolando I. https://orcid.org/0000-0002-9446-074X
Chen, Eric Yu Hai https://orcid.org/0000-0002-5247-3593
Choi, Jimmy
Conus, Philippe
Corcoran, Cheryl M. https://orcid.org/0000-0002-8902-4353
Cornblatt, Barbara A.
Diaz-Caneja, Covadonga M. https://orcid.org/0000-0001-8538-3175
Ellman, Lauren M.
Fusar-Poli, Paolo
Gaspar, Pablo A. https://orcid.org/0000-0002-9682-5327
Gerber, Carla
Glenthøj, Louise Birkedal
Horton, Leslie E.
Hui, Christy Lai Ming
Kambeitz, Joseph https://orcid.org/0000-0002-8988-3959
Kambeitz-Ilankovic, Lana
Keshavan, Matcheri S.
Kim, Minah https://orcid.org/0000-0001-8668-0817
Kim, Sung-Wan https://orcid.org/0000-0002-6739-2163
Koutsouleris, Nikolaos https://orcid.org/0000-0001-6825-6262
Kwon, Jun Soo https://orcid.org/0000-0002-1060-1462
Langbein, Kerstin
Mamah, Daniel
Mittal, Vijay A. https://orcid.org/0000-0001-9017-5119
Nordentoft, Merete
Pearlson, Godfrey D.
Perez, Jesus
Perkins, Diana O. https://orcid.org/0000-0001-9396-2206
Powers, Albert R. https://orcid.org/0000-0003-3057-5043
Sabb, Fred W.
Schiffman, Jason
Shah, Jai L. https://orcid.org/0000-0002-7549-6990
Silverstein, Steven M. https://orcid.org/0000-0002-0699-0960
Smesny, Stefan
Stone, William S. https://orcid.org/0000-0003-2932-7288
Strauss, Gregory P.
Upthegrove, Rachel https://orcid.org/0000-0001-8204-5103
Verma, Swapna K.
Wang, Jijun https://orcid.org/0000-0001-5427-7425
Wolf, Daniel H. https://orcid.org/0000-0002-9731-8781
Zhang, Tianhong https://orcid.org/0000-0002-5379-7119
Bouix, Sylvain https://orcid.org/0000-0003-1326-6054
Pasternak, Ofer
Cho, Kang-Ik K. https://orcid.org/0000-0001-7135-3848
Coleman, Michael J.
Dwyer, Dominic https://orcid.org/0000-0003-3949-5867
Nunez, Angela
Tamayo, Zailyn
Wood, Stephen J. https://orcid.org/0000-0003-4186-5919
Kahn, Rene S. https://orcid.org/0000-0001-5909-8004
Kane, John M.
McGorry, Patrick D.
Bearden, Carrie E. https://orcid.org/0000-0002-8516-923X
Nelson, Barnaby
Woods, Scott W. https://orcid.org/0000-0002-3103-5228
Shenton, Martha E. https://orcid.org/0000-0003-4235-7879
,
Light, Gregory A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01MH124639, U24MH124629)
Wellcome Trust (220664/Z/20/Z)
Foundation for the National Institutes of Health
- License Information
-
More Information
Article History
Received: 29 October 2024
Accepted: 24 February 2025
First Online: 6 June 2025
Change Date: 16 June 2025
Change Type: Update
Change Details: In the original version of this article, in Table 2, a formatting issue resulted in the entry “222 M (38.9%)” under the column “Sex at Birth” appearing across two lines rather than on a single line. This has now been corrected.
Competing interests
: The authors declare the following competing interests: B.H.E. is part of the Advisory Board of Boehringer Ingelheim, Lundbeck Pharma A/S; and has received lecture fees from Boehringer Ingelheim, Otsuka Pharma Scandinavia AB, and Lundbeck Pharma A/S; C.A. has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda; C.D.C. has received grant support from Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation and honoraria or travel support from Angelini, Janssen, and Viatris; C.M.C. is an Associate Editor of Nature: Schizophrenia; D.D. has received honorary funds for one educational seminar for CSL Sequiris; D.O.P. has been a consultant to Alkermes; E.Y.H.C. has received speaker fees at non-promotional educational events; GAL has been a consultant for Bristol Myers Squibb, Cerevel, Johnson & Johnson, Neurocrine, NeuroSig, and Sosei-Heptares; J.K. has received speaking or consulting fees from Janssen, Boehringer Ingelheim, ROVI and Lundbeck; J.M.K. is a consultant to or receives honoraria and/or travel support and/or speakers fees from Alkermes, Allergan, Boehringer-Ingelheim, Cerevel, Dainippon Sumitomo, H. Lundbeck, HealthRhythms, HLS Therapeutics, Indivior, Intracellular Therapies, Janssen Pharmaceutical, Johnson & Johnson, Karuna Therapeutics/Bristol Myers Squibb, LB Pharmaceuticals, Mapi, Maplight, Merck, Minerva, Neurocrine, Newron, Novartis, NW PharmaTech, Otsuka, Roche, Saladax, Sunovion, and Teva; and is on Advisory Boards for Alkermes, Boehringer-Ingelheim, Cerevel, Click Therapeutics, Karuna/BMS, Lundbeck, Merck, Newron, Novartis, Otsuka, Sumitomo, Teva, and Terran; and has received grant support from Lundbeck, Janssen, Otsuka, and Sunovion; and has shareholder interest in Cerevel (public/stock), HealthRhythms (private/stock options), Karuna/BMS (public), LB Pharmaceuticals (private/stock options), North Shore Therapeutics (private/stock), and Vanguard Research Group (private/40% owner); P.F.P. has received research funds or personal fees from Lundbeck, Angelini, Menarini, Sunovion, Boehringer Ingelheim, Proxymm Science, Otsuka, outside the current study; R.S.K. has been a consultant to Alkermes and Boehringer-Ingelheim; R.U. has received speaker fees at non-promotional educational event: Otsuka: Consultancy for Viatris and Springer Healthcare. Honorary General Secretary British Association for Psychopharmacology (unpaid); S.W.W. has received speaking fees from the American Psychiatric Association and from Medscape Features. He has been granted US patent No. 8492418 B2 for a method of treating prodromal schizophrenia with glycine agonists. He owns stock in NW PharmaTech; and Z.T. has been a consultant for Manifest Technologies. All other authors report no biomedical financial interests or potential conflicts of interest.
